FAAH genetic variation enhances fronto-amygdala function in mouse and human

Iva Dincheva, Andrew T. Drysdale, Catherine Hartley, David C. Johnson, Deqiang Jing, Elizabeth C. King, Stephen Ra, J. Megan Gray, Ruirong Yang, Ann Marie DeGruccio, Chienchun Huang, Benjamin F. Cravatt, Charles E. Glatt, Matthew N. Hill, B. J. Casey, Francis S. Lee

Research output: Contribution to journalArticle

Abstract

Cross-species studies enable rapid translational discovery and produce the broadest impact when both mechanism and phenotype are consistent across organisms. We developed a knock-in mouse that biologically recapitulates a common human mutation in the gene for fatty acid amide hydrolase (FAAH) (C385A; rs324420), the primary catabolic enzyme for the endocannabinoid anandamide. This common polymorphism impacts the expression and activity of FAAH, thereby increasing anandamide levels. Here, we show that the genetic knock-in mouse and human variant allele carriers exhibit parallel alterations in biochemisty, neurocircuitry and behaviour. Specifically, there is reduced FAAH expression associated with the variant allele that selectively enhances fronto-amygdala connectivity and fear extinction learning, and decreases anxiety-like behaviours. These results suggest a gain of function in fear regulation and may indicate for whom and for what anxiety symptoms FAAH inhibitors or exposure-based therapies will be most efficacious, bridging an important translational gap between the mouse and human.

Original languageEnglish (US)
Article number6395
JournalNature Communications
Volume6
DOIs
StatePublished - 2015

Fingerprint

fatty acids
Amygdala
amides
mice
anxiety
fear
Fear
Anxiety
Alleles
Implosive Therapy
Endocannabinoids
phenotype
polymorphism
mutations
Polymorphism
organisms
genes
inhibitors
learning
enzymes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Chemistry(all)
  • Physics and Astronomy(all)

Cite this

Dincheva, I., Drysdale, A. T., Hartley, C., Johnson, D. C., Jing, D., King, E. C., ... Lee, F. S. (2015). FAAH genetic variation enhances fronto-amygdala function in mouse and human. Nature Communications, 6, [6395]. https://doi.org/10.1038/ncomms7395

FAAH genetic variation enhances fronto-amygdala function in mouse and human. / Dincheva, Iva; Drysdale, Andrew T.; Hartley, Catherine; Johnson, David C.; Jing, Deqiang; King, Elizabeth C.; Ra, Stephen; Gray, J. Megan; Yang, Ruirong; DeGruccio, Ann Marie; Huang, Chienchun; Cravatt, Benjamin F.; Glatt, Charles E.; Hill, Matthew N.; Casey, B. J.; Lee, Francis S.

In: Nature Communications, Vol. 6, 6395, 2015.

Research output: Contribution to journalArticle

Dincheva, I, Drysdale, AT, Hartley, C, Johnson, DC, Jing, D, King, EC, Ra, S, Gray, JM, Yang, R, DeGruccio, AM, Huang, C, Cravatt, BF, Glatt, CE, Hill, MN, Casey, BJ & Lee, FS 2015, 'FAAH genetic variation enhances fronto-amygdala function in mouse and human', Nature Communications, vol. 6, 6395. https://doi.org/10.1038/ncomms7395
Dincheva, Iva ; Drysdale, Andrew T. ; Hartley, Catherine ; Johnson, David C. ; Jing, Deqiang ; King, Elizabeth C. ; Ra, Stephen ; Gray, J. Megan ; Yang, Ruirong ; DeGruccio, Ann Marie ; Huang, Chienchun ; Cravatt, Benjamin F. ; Glatt, Charles E. ; Hill, Matthew N. ; Casey, B. J. ; Lee, Francis S. / FAAH genetic variation enhances fronto-amygdala function in mouse and human. In: Nature Communications. 2015 ; Vol. 6.
@article{953a135ad2114bfe9364ac95c3f53836,
title = "FAAH genetic variation enhances fronto-amygdala function in mouse and human",
abstract = "Cross-species studies enable rapid translational discovery and produce the broadest impact when both mechanism and phenotype are consistent across organisms. We developed a knock-in mouse that biologically recapitulates a common human mutation in the gene for fatty acid amide hydrolase (FAAH) (C385A; rs324420), the primary catabolic enzyme for the endocannabinoid anandamide. This common polymorphism impacts the expression and activity of FAAH, thereby increasing anandamide levels. Here, we show that the genetic knock-in mouse and human variant allele carriers exhibit parallel alterations in biochemisty, neurocircuitry and behaviour. Specifically, there is reduced FAAH expression associated with the variant allele that selectively enhances fronto-amygdala connectivity and fear extinction learning, and decreases anxiety-like behaviours. These results suggest a gain of function in fear regulation and may indicate for whom and for what anxiety symptoms FAAH inhibitors or exposure-based therapies will be most efficacious, bridging an important translational gap between the mouse and human.",
author = "Iva Dincheva and Drysdale, {Andrew T.} and Catherine Hartley and Johnson, {David C.} and Deqiang Jing and King, {Elizabeth C.} and Stephen Ra and Gray, {J. Megan} and Ruirong Yang and DeGruccio, {Ann Marie} and Chienchun Huang and Cravatt, {Benjamin F.} and Glatt, {Charles E.} and Hill, {Matthew N.} and Casey, {B. J.} and Lee, {Francis S.}",
year = "2015",
doi = "10.1038/ncomms7395",
language = "English (US)",
volume = "6",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - FAAH genetic variation enhances fronto-amygdala function in mouse and human

AU - Dincheva, Iva

AU - Drysdale, Andrew T.

AU - Hartley, Catherine

AU - Johnson, David C.

AU - Jing, Deqiang

AU - King, Elizabeth C.

AU - Ra, Stephen

AU - Gray, J. Megan

AU - Yang, Ruirong

AU - DeGruccio, Ann Marie

AU - Huang, Chienchun

AU - Cravatt, Benjamin F.

AU - Glatt, Charles E.

AU - Hill, Matthew N.

AU - Casey, B. J.

AU - Lee, Francis S.

PY - 2015

Y1 - 2015

N2 - Cross-species studies enable rapid translational discovery and produce the broadest impact when both mechanism and phenotype are consistent across organisms. We developed a knock-in mouse that biologically recapitulates a common human mutation in the gene for fatty acid amide hydrolase (FAAH) (C385A; rs324420), the primary catabolic enzyme for the endocannabinoid anandamide. This common polymorphism impacts the expression and activity of FAAH, thereby increasing anandamide levels. Here, we show that the genetic knock-in mouse and human variant allele carriers exhibit parallel alterations in biochemisty, neurocircuitry and behaviour. Specifically, there is reduced FAAH expression associated with the variant allele that selectively enhances fronto-amygdala connectivity and fear extinction learning, and decreases anxiety-like behaviours. These results suggest a gain of function in fear regulation and may indicate for whom and for what anxiety symptoms FAAH inhibitors or exposure-based therapies will be most efficacious, bridging an important translational gap between the mouse and human.

AB - Cross-species studies enable rapid translational discovery and produce the broadest impact when both mechanism and phenotype are consistent across organisms. We developed a knock-in mouse that biologically recapitulates a common human mutation in the gene for fatty acid amide hydrolase (FAAH) (C385A; rs324420), the primary catabolic enzyme for the endocannabinoid anandamide. This common polymorphism impacts the expression and activity of FAAH, thereby increasing anandamide levels. Here, we show that the genetic knock-in mouse and human variant allele carriers exhibit parallel alterations in biochemisty, neurocircuitry and behaviour. Specifically, there is reduced FAAH expression associated with the variant allele that selectively enhances fronto-amygdala connectivity and fear extinction learning, and decreases anxiety-like behaviours. These results suggest a gain of function in fear regulation and may indicate for whom and for what anxiety symptoms FAAH inhibitors or exposure-based therapies will be most efficacious, bridging an important translational gap between the mouse and human.

UR - http://www.scopus.com/inward/record.url?scp=84924189188&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924189188&partnerID=8YFLogxK

U2 - 10.1038/ncomms7395

DO - 10.1038/ncomms7395

M3 - Article

VL - 6

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

M1 - 6395

ER -